Literature DB >> 20450565

[National survey of blood pressure control rate in Chinese hypertensive outpatients-China STATUS].

Da-yi Hu1, Li-sheng Liu, Jin-ming Yu, Chong-hua Yao.   

Abstract

OBJECTIVE: To investigate the blood pressure control rate and related influencing factors in hypertensive outpatients.
METHODS: In this multicentre, cross-sectional registration survey, hypertensive outpatients were recruited from department of cardiology, nephrology and endocrinology of 92 tertiary hospitals in 22 cites across China. Each centre enrolled more than 50 hypertensive outpatients aged 18 years or older between 20 April 2009 and 31 May 2009. Outpatients were surveyed by clinical interview with BP measurement and questionnaire.
RESULTS: A total of 5086 subjects were enrolled, 2032 in department of cardiology, 1510 in department of endocrinology and 1544 in department of nephrology, 27.1% and 25.3% patients were in Grade 2 or Grade 3 hypertension, 37.2% patients were complicated with diabetes, 22.4% with coronary artery disease, and 18.4% with renal-dysfunction. Overall, controlled BP was achieved in 30.6% patients. The control rate was 45.9% in uncomplicated hypertensive patients, 31.3% in hypertensive patients with coronary artery disease, 14.9% in patients with diabetes, and 13.2% in patients with renal-dysfunction. Calcium channel blocker (56.6%) and angiotensin-II receptor blockers (32.0%) were the most frequently used medications. The mean number of antihypertensive agents prescribed per patient was 1.73, over 54.1% patients were treated with more than 2 antihypertensive drugs. Combination therapy or single-pill combination with various anti-hypertensive components was prescribed to 8.3% and 12.7% hypertensive patients as initial therapy. Multiple logistic regression analysis showed that lower BMI, no alcohol intake, free medical care, no diabetes, no renal-dysfunction, lipid-lowering therapy, shorter interval of visiting physicians, regular taking antihypertensive medications, physical activity were the factors related to satisfactory blood pressure control rate in hypertensive outpatients.
CONCLUSIONS: Blood pressure control rate among Chinese hypertensive outpatients was increased compared with epidemiological survey in 2002. BMI, co-morbidities, lower combination treatment rate, poor compliance were the key reasons for lower BP control rate. Increased use of combination therapy instead of monotherapy should be encouraged to hypertensive outpatients to improve BP control rate.

Entities:  

Mesh:

Year:  2010        PMID: 20450565

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  10 in total

1.  Efficacy and tolerability of once-daily 160 mg valsartan in Chinese patients with mild to moderate hypertension.

Authors:  Ningling Sun; Yingqing Feng; Pingjin Gao; Xiaoping Chen; Litong Qi; Shuyang Zhang; Yugang Dong; Xinchun Yang; Xinli Li; Yundai Chen; Lingli Liu
Journal:  Exp Ther Med       Date:  2017-01-17       Impact factor: 2.447

2.  Development, Reliability, and Validity of the Home Blood Pressure Monitoring Adherence Scale for Patients with Chronic Kidney Disease.

Authors:  Yamin Wang; Kun Li; Huiqun Li; Wenbo Zhao; Yanru Chen; Hongli Shang; Min Zhang; Jing Zheng
Journal:  Patient Prefer Adherence       Date:  2020-10-12       Impact factor: 2.711

3.  Efficacy of Pharmaceutical Care in Patients with Type 2 Diabetes Mellitus and Hypertension: A Randomized Controlled Trial.

Authors:  Weibo Wang; Lijuan Geng; Chenjing Sun; Hui Li; Jinying Wang
Journal:  Int J Clin Pract       Date:  2022-03-24       Impact factor: 3.149

Review 4.  High-dose calcium channel blocker (CCB) monotherapy vs combination therapy of standard-dose CCBs and angiotensin receptor blockers for hypertension: a meta-analysis.

Authors:  T He; X Liu; Y Li; X Y Liu; Q Y Wu; M L Liu; H Yuan
Journal:  J Hum Hypertens       Date:  2016-08-11       Impact factor: 3.012

Review 5.  Chinese Hypertension Guidelines.

Authors:  Ji-Guang Wang
Journal:  Pulse (Basel)       Date:  2015-04-29

6.  A nationwide assessment of blood pressure control and the associated factors in Chinese type 2 diabetes mellitus patients.

Authors:  Yu-Qing Zhang; Yong Li; Yu-Gang Dong; Yan-Hua Wu; Rui Bian; Ji-Hu Li; Li-Nong Ji
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-10-11       Impact factor: 3.738

7.  Efficacy and safety of valsartan/amlodipine single-pill combination in 11,422 Chinese patients with hypertension: an observational study.

Authors:  Dayi Hu; Lisheng Liu; Weimin Li
Journal:  Adv Ther       Date:  2014-07-02       Impact factor: 3.845

8.  Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.

Authors:  Jie Song; Chang-Sheng Sheng; Qi-Fang Huang; Li-Hua Li; Chang-Sheng Ma; Xiao-Hui Guo; Li-Nong Ji; Ji-Guang Wang
Journal:  J Hypertens       Date:  2016-08       Impact factor: 4.844

9.  Hypertension Attitude PersPEctives and Needs (HAPPEN): A Real-World Survey of Physicians and Patients With Hypertension in China.

Authors:  Ross D Feldman; Lisheng Liu; Zhaosu Wu; Yuqing Zhang; Xueqing Yu; Xin-Hua Zhang
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-10-26       Impact factor: 3.738

10.  Trajectories of Outpatient Service Utilisation of Hypertensive Patients in Tertiary Hospitals in China.

Authors:  Zijing Pan; Wanchun Xu; Zhong Li; Chengzhong Xu; Fangfang Lu; Pei Zhang; Liang Zhang; Ting Ye
Journal:  Int J Environ Res Public Health       Date:  2020-01-29       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.